Ludwig, Laureen
Seifert, Roland
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 7 May 2024
Accepted: 6 June 2024
First Online: 20 June 2024
Declarations
:
: L.L declares no competing interest. R.S. is the Editor-in-Chief auf Naunyn-Schmiedebergs Arch Pharmacol and follows the editorial guidelines of the journal for acting as author ().
: This work was carried out in accordance with the guidelines of good scientific practice of Hannover Medical School () and officially registered as a doctoral project for Laureen Ludwig. Hannover Medical School follows the guidelines of the German Research Foundation (DFG).
: Not applicable, as publicly available information is used as a data source.
: The authors declare no competing interests.